Molecule Details
| InChIKey | SFJVTILNSUYYFI-CLJLJLNGSA-N |
|---|---|
| Compound Name | 3-[[(3R,5R)-1-[2-(tert-butylamino)-2-oxoethyl]-5-cyclohexyl-8-methyl-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]carbamoylamino]-N-methylsulfonylbenzamide |
| Canonical SMILES | Cc1ccc2c(c1)N(CC(=O)NC(C)(C)C)C(=O)[C@H](NC(=O)Nc1cccc(C(=O)NS(C)(=O)=O)c1)C[C@@H]2C1CCCCC1 |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 9.59 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile